ANDA 77256, held by Epic Pharma LLC. Trandolapril.
As of Nov 14, 2026, ANDA 77256 (Trandolapril), held by Epic Pharma LLC, was first approved by FDA on Jun 12, 2007, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 12, 2007 | Original application | Approved | None posted |
| Trandolapril1MG · tablet;oral | Trandolapril | Discontinued |
| Trandolapril2MG · tablet;oral | Trandolapril | Discontinued |
| Trandolapril4MG · tablet;oral | Trandolapril | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
